Cargando…

Relevance of Smoking Habit in Severe Asthma Patients: Evidence from the Severe Asthma Network in Italy (SANI) Registry

Smoking habit is still fairly common among asthmatics. So far, the impact of smoke on severe asthma burden has not been specifically investigated. We aimed to estimate the frequency of smoking habit among severe asthma patients, their clinical features, and the impact of smoke on asthma outcomes. Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Caminati, Marco, Guarnieri, Gabriella, Paggiaro, Pierluigi, Vianello, Andrea, Crisafulli, Ernesto, Vaia, Rachele, Senna, Gianenrico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784435/ https://www.ncbi.nlm.nih.gov/pubmed/36556081 http://dx.doi.org/10.3390/jcm11247465

Ejemplares similares

Sex Differences in Severe Asthma: Results From Severe Asthma Network in Italy-SANI
por: Senna, Gianenrico, et al.
Publicado: (2020)

Frequency of Tiotropium Bromide Use and Clinical Features of Patients with Severe Asthma in a Real-Life Setting: Data from the Severe Asthma Network in Italy (SANI) Registry
por: Puggioni, Francesca, et al.
Publicado: (2020)

SANI-Severe Asthma Network in Italy: a way forward to monitor severe asthma
por: Senna, G., et al.
Publicado: (2017)

Severe Asthma, Telemedicine, and Self-Administered Therapy: Listening First to the Patient
por: Guarnieri, Gabriella, et al.
Publicado: (2022)

Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI)
por: Canonica, Giorgio Walter, et al.
Publicado: (2020)

Uncontrolled Asthma: Unmet Needs in the Management of Patients
por: Caminati, Marco, et al.
Publicado: (2021)

New horizons for the treatment of severe, eosinophilic asthma: benralizumab, a novel precision biologic
por: Caminati, Marco, et al.
Publicado: (2019)

Shadow cost of oral corticosteroids-related adverse events: A pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry
por: Canonica, Giorgio Walter, et al.
Publicado: (2019)

Hidden Comorbidities in Asthma: A Perspective for a Personalized Approach
por: Maule, Matteo, et al.
Publicado: (2023)

COVID-19 Vaccination in Patients with Severe Asthma on Biologic Treatment: Safety, Tolerability, and Impact on Disease Control
por: Caminati, Marco, et al.
Publicado: (2021)

Targeting eosinophils: severe asthma and beyond
por: Caminati, Marco, et al.
Publicado: (2019)

Biologics in Severe Eosinophilic Asthma: Three-Year Follow-Up in a SANI Single Center
por: Solidoro, Paolo, et al.
Publicado: (2022)

Clinical response to biologicals for severe asthma: any relevance for sex in different age ranges?
por: Benoni, Roberto, et al.
Publicado: (2022)

Asthma control in primary care: the results of an observational cross-sectional study in Italy and Spain
por: Magnoni, Maria Sandra, et al.
Publicado: (2017)

Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity
por: Caminati, Marco, et al.
Publicado: (2021)

Organization, Clinical and Management Indicators on the First Year of Activity of an Outpatient Clinic Dedicated to the Diagnosis and Treatment of Severe Asthma in Italy
por: Tognella, Silvia, et al.
Publicado: (2021)

Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life()
por: Bagnasco, Diego, et al.
Publicado: (2021)

Low-dose anti-IL 5 treatment in idiopathic hypereosinophilic syndrome: towards a precision medicine approach for remission maintenance
por: Caminati, Marco, et al.
Publicado: (2023)

Trends and determinants of Emergency Room admissions for asthma: A retrospective evaluation in Northeast Italy
por: Caminati, Marco, et al.
Publicado: (2019)

Patient and physician perspectives on biological treatment in severe asthma: a Severe Asthma Network Italy survey
por: Crimi, Claudia, et al.
Publicado: (2023)

Who Is Really at Risk for Anaphylaxis Due to COVID-19 Vaccine?
por: Caminati, Marco, et al.
Publicado: (2021)

Benralizumab Efficacy in Late Non-Responders to Mepolizumab and Variables Associated with Occurrence of Switching: A Real-Word Perspective
por: Caminati, Marco, et al.
Publicado: (2023)

Prevalence of severe asthma according to the drug regulatory agency perspective: An Italian experience
por: Vianello, A., et al.
Publicado: (2019)

Overcoming Barriers to the Effective Management of Severe Asthma in Italy
por: Paggiaro, Pierluigi, et al.
Publicado: (2021)

Therapeutic interventions in severe asthma
por: Canonica, Giorgio Walter, et al.
Publicado: (2016)

The potential protective role of corticosteroid therapy in patients with asthma and COPD against COVID-19
por: Furci, Fabiana, et al.
Publicado: (2021)

Asthma under/misdiagnosis in primary care setting: an observational community-based study in Italy
por: Magnoni, Maria Sandra, et al.
Publicado: (2015)

Fatal asthma; is it still an epidemic?
por: Vianello, Andrea, et al.
Publicado: (2016)

Upsides and downsides of a telecounselling model of integrated asthma management between general practitioners and specialists
por: Furci, Fabiana, et al.
Publicado: (2022)

The intriguing possibility of using probiotics in allergen-specific immunotherapy
por: Furci, Fabiana, et al.
Publicado: (2023)

Drop-out rate among patients treated with omalizumab for severe asthma: Literature review and real-life experience
por: Caminati, M., et al.
Publicado: (2016)

Relative Humidity and Its Impact on the Immune System and Infections
por: Guarnieri, Gabriella, et al.
Publicado: (2023)

Asthma management among allergists in Italy: results from a survey
por: Magnoni, M. S., et al.
Publicado: (2017)

Targeted therapy in severe asthma today: focus on immunoglobulin E
por: Pelaia, Girolamo, et al.
Publicado: (2017)

Characterisation of patients with severe asthma in the UK Severe Asthma Registry in the biologic era
por: Jackson, David J, et al.
Publicado: (2021)

Long-Term Efficacy of Mepolizumab at 3 Years in Patients with Severe Asthma: Comparison with Clinical Trials and Super Responders
por: Bagnasco, Diego, et al.
Publicado: (2023)

Comorbidities are associated with different features of severe asthma
por: Novelli, Federica, et al.
Publicado: (2018)

On-line Italian register for severe/non-controlled asthma
por: Bresciani, Megon, et al.
Publicado: (2013)

Correlation between α1-Antitrypsin Deficiency and SARS-CoV-2 Infection: Epidemiological Data and Pathogenetic Hypotheses
por: Vianello, Andrea, et al.
Publicado: (2021)

Oral health in asthmatic patients: a review: Asthma and its therapy may impact on oral health
por: Gani, Federica, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_d0ujs5921odtua1fetal9b7r22